Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma

Oncology Reports

Volumn 34, Issue 5, 2015, Pages 2403-2412

  Huang, Ziling ^a   Huang, Lanshan ^a   Shen, Siqiao ^a   Li, Jia ^a   Lu, Huiping ^a   Mo, Weijia ^a   Dang, Yiwu ^a   Luo, Dianzhong ^a   Chen, Gang ^a   Feng, Zhenbo ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; MALAT1; Mithramycin A; Sp1; Sp3; Transcriptional regulation

Indexed keywords

ALPHA FETOPROTEIN; LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN; PROTEIN BINDING; SP1 PROTEIN, HUMAN; SP3 PROTEIN, HUMAN;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; UPREGULATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TRANSCRIPTION INITIATION;

BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, LONG NONCODING; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84941953028     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4259     Document Type: Article

References (45)

1. Kapranov P, Willingham AT and Gingeras TR: Genome-wide transcription and the implications for genomic organization. Nat Rev Genet 8: 413-423, 2007.
2. Lau E: Non-coding RNA: Zooming in on lncRNA functions. Nat Rev Genet 15: 574-575, 2014.
3. Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell 136: 629-641, 2009.
4. Ponjavic J, Ponting CP and Lunter G: Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res 17: 556-565, 2007.
5. Yang G, Lu X and Yuan L: LncRNA: A link between RNA and cancer. Biochim Biophys Acta 1839: 1097-1109, 2014.
6. Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34: 577-586, 2013.
7. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 57: 1882-1892, 2013.
8. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, Ye L and Zhang X: Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem 287: 26302-26311, 2012.
9. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250, 2011.
10. Takahashi K, Yan I, Haga H and Patel T: Long noncoding RNA in liver diseases. Hepatology 60: 744-753, 2014.
11. Mohamadkhani A: Long Noncoding RNAs in interaction with RNA binding proteins in hepatocellular carcinoma. Hepat Mon 14: e18794, 2014.
12. Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer 111: 736-748, 2014.
13. Dong Y, Liang G, Yuan B, Yang C, Gao R and Zhou X: MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol 36:1477-1486, 2015.
14. Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39: 925-938, 2010.
15. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29: 1810-1816, 2012.
16. Yang JH, Li JH, Jiang S, Zhou H and Qu LH: ChIPBase: A database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res 41 (D1): D177-D187, 2013.
17. Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q, Cen B and Ji A: Regulation of lncRNA expression. Cell Mol Biol Lett 19: 561-575, 2014.
18. Uesaka M, Nishimura O, Go Y, Nakashima K, Agata K and Imamura T: Bidirectional promoters are the major source of gene activation-associated non-coding RNAs in mammals. BMC Genomics 15: 35, 2014.
19. Alam T, Medvedeva YA, Jia H, Brown JB, Lipovich L and Bajic VB: Promoter analysis reveals globally differential regulation of human long non-coding RNA and protein-coding genes. PLoS One 9: e109443, 2014.
20. Chen G, Kronenberger P, Teugels E, Umelo IA and De Grève J: Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: The effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med 10: 28, 2012.
21. Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J and Xie K: Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer 110: 2682-2690, 2007.
22. Narayan VA, Kriwacki RW and Caradonna JP: Structures of zinc finger domains from transcription factor Sp1. Insights into sequence-specific protein-DNA recognition. J Biol Chem 272: 7801-7809, 1997.
23. Li L and Davie JR: The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat 192: 275-283, 2010.
24. Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, et al: Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 49: 2949-2959, 2013.
25. Gutschner T, Hämmerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al: The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 73: 1180-1189, 2013.
26. Gutschner T, Hämmerle M and Diederichs S: MALAT1 - a paradigm for long noncoding RNA function in cancer. J Mol Med Berl 91: 791-801, 2013.
27. Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041, 2003.
28. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 8: 39, 2007.
29. Wang J, Wang H, Zhang Y, Zhen N, Zhang L, Qiao Y, Weng W, Liu X, Ma L, Xiao W, et al: Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer. Cell Signal 26: 1048-1059, 2014.
30. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett 584: 4575-4580, 2010.
31. Li B, Chen P, Qu J, Shi L, Zhuang W, Fu J, Li J, Zhang X, Sun Y and Zhuang W: Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J Biol Chem 289: 29365-29375, 2014.
32. Bonasio R and Shiekhattar R: Regulation of transcription by long noncoding RNAs. Annu Rev Genet 48: 433-455, 2014.
33. Beishline K and Azizkhan-Clifford J: Sp1 and the 'hallmarks of cancer'. FEBS J 282: 224-258, 2015.
34. Sankpal UT, Maliakal P, Bose D, Kayaleh O, Buchholz D and Basha R: Expression of specificity protein transcription factors in pancreatic cancer and their association in prognosis and therapy. Curr Med Chem 19: 3779-3786, 2012.
35. Tong Y, Tan Y, Zhou C and Melmed S: Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene 26: 5596-5605, 2007.
36. Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA and Lu D: Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 17: 1648-1652, 2008.
37. Galvagni F, Capo S and Oliviero S: Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. J Mol Biol 306: 985-996, 2001.
38. Li S, Wang Q, Qiang Q, Shan H, Shi M, Chen B, Zhao S and Yuan L: Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol: 16 March, 2015 (Epub ahead of print).
39. Mir MA, Majee S, Das S and Dasgupta D: Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A3. Bioorg Med Chem 11: 2791-2801, 2003.
40. Choi ES, Nam JS, Jung JY, Cho NP and Cho SD: Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer. Sci Rep 4: 7162, 2014.
41. Osada N, Kosuge Y, Ishige K and Ito Y: Mithramycin, an agent for developing new therapeutic drugs for neurodegenerative diseases. J Pharmacol Sci 122: 251-256, 2013.
42. Kajita Y, Kato T Jr, Tamaki S, Furu M, Takahashi R, Nagayama S, Aoyama T, Nishiyama H, Nakamura E, Katagiri T, et al: The transcription factor Sp3 regulates the expression of a metastasis-related marker of sarcoma, actin filament-associated protein 1-like 1 (AFAP1L1). PLoS One 8: e49709, 2013.
43. Huong PT, Soung NK, Jang JH, Cha-Molstad HJ, Sakchaisri K, Kim SO, Jang JM, Kim KE, Lee KS, Kwon YT, et al: Regulation of CEP131 gene expression by SP1. Gene 513: 75-81, 2013.
44. Zhang M, Mathur A, Zhang Y, Xi S, Atay S, Hong JA, Datrice N, Upham T, Kemp CD, Ripley RT, et al: Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells. Cancer Res 72: 4178-4192, 2012.
45. Hsu TI, Wang MC, Chen SY, Huang ST, Yeh YM, Su WC, Chang WC and Hung JJ: Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth. Mol Pharmacol 82: 1115-1128, 2012.